|
|
|
Volumn 64, Issue 12, 2006, Pages 2359-2366
|
|
Rheumatoid arthritis and osteoporosis: trends in their treatments
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
GLUCOCORTICOID;
IMMUNOGLOBULIN G;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
BONE MATRIX;
BONE REMODELING;
CLINICAL TRIAL;
HUMAN;
METABOLISM;
OSTEOBLAST;
OSTEOCLAST;
OSTEOLYSIS;
OSTEOPOROSIS;
PHYSIOLOGY;
REVIEW;
RHEUMATOID ARTHRITIS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BONE DENSITY CONSERVATION AGENTS;
BONE MATRIX;
BONE REMODELING;
BONE RESORPTION;
CLINICAL TRIALS;
DIPHOSPHONATES;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOGLOBULIN G;
OSTEOBLASTS;
OSTEOCLASTS;
OSTEOPOROSIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 39049181292
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (19)
|
